GRDN Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Guardian Pharmacy Svcs Inc (GRDN) following the 2026 Q2 hedge fund 13F filings?

As of today, GRDN has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), GRDN gained -8.2% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Guardian Pharmacy Svcs Inc (GRDN)

168 + Investors. Track Smart Money conviction in GRDN. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — GRDN

Based on 168 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 7 quarters in a row

last 6Q

For 7 consecutive quarters, more hedge funds added GRDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

168 hedge funds hold GRDN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +127% more funds vs a year ago

fund count last 6Q

+94 new funds entered over the past year (+127% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 65% buying

108 buying58 selling

Last quarter: 108 funds were net buyers (56 opened a brand new position + 52 added to an existing one). Only 58 were sellers (42 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+23 vs last Q)

new funds entering per quarter

Funds opening a new GRDN position: 36 → 23 → 33 → 56. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 51% entered in last year

■ 3% conviction (2yr+) ■ 46% medium ■ 51% new

Only 5 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +61% but shares only +42% — price-driven

Value

+61%

+41%

Last quarter: the total dollar value of institutional holdings rose +61%, but actual share count only changed +42%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

15 → 36 → 23 → 33 → 56 new funds/Q

New funds entering each quarter: 36 → 23 → 33 → 56. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 63% of holders entered in last year

■ 5% veterans ■ 32% 1-2yr ■ 63% new

Of 169 current holders: 107 (63%) entered in the past year, only 8 (5%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

🏆

Elite ownership — 44% AUM from top-100 funds

44% from top-100 AUM funds

46 of 168 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in GRDN. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

5.3

out of 10

Moderate Exit Risk

Exit risk score 5.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	168	127	32.28%
13F Shares	28M	20M	41.6%
Total Value	$969M	$601M	61.35%
New Positions	56	33	+23
Increased Positions	52	51	+1
Closed Positions	15	17	-2
Reduced Positions	42	32	+10
Total Calls	0	0	-
Total Puts	1	1	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

168

127

32.28%

13F Shares

28M

20M

41.6%

Total Value

$969M

$601M

61.35%

New Positions

+23

Increased Positions

Closed Positions

-2

Reduced Positions

+10

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

168 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GRDN. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 GRDN holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Boone Capital Management LLC	6.97%	711,939	$29.8M
2	Valiant Capital Management, L.P.	2.01%	1,186,658	$49.7M
3	Lisanti Capital Growth, LLC	1.40%	152,025	$6.4M
4	Aristotle Capital Boston, LLC	1.19%	422,427	$17.7M
5	Kiker Wealth Management, LLC	1.07%	65,604	$2.7M
6	Mitchell Capital Management Co	0.92%	143,873	$6.0M
7	Crews Bank & Trust	0.55%	101,127	$4.2M
8	Ranger Investment Management, L.P.	0.46%	173,458	$7.3M
9	Braun Stacey Associates Inc	0.40%	339,947	$14.2M
10	Seven Grand Managers, LLC	0.34%	200,000	$8.4M
11	Riverbridge Partners LLC	0.29%	244,585	$10.2M
12	Peregrine Capital Management LLC	0.25%	185,383	$7.8M
13	Globeflex Capital L P	0.24%	44,354	$1.9M
14	Legato Capital Management LLC	0.22%	63,310	$2.7M
15	Hussman Strategic Advisors, INC.	0.20%	21,000	$879K
16	Yorktown Management & Research Co Inc	0.20%	7,850	$329K
17	Woodline Partners LP	0.17%	1,306,340	$54.7M
18	VARCOV Co.	0.16%	10,098	$423K
19	Driehaus Capital Management LLC	0.12%	510,161	$21.4M
20	Diametric Capital, LP	0.12%	26,173	$1.1M
21	Round Rock Advisors LLC	0.10%	18,524	$776K
22	Dark Forest Capital Management LP	0.10%	36,041	$1.5M
23	Silvercrest Asset Management Group LLC	0.09%	345,229	$14.5M
24	J. Goldman & Co LP	0.09%	79,219	$3.3M
25	Alpine Woods Capital Investors, LLC	0.08%	8,996	$377K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Guardian Pharmacy Svcs Inc (GRDN)

What does the Smart Money Trend signal show for GRDN?

Buying streak — 7 quarters in a row: For 7 consecutive quarters, more hedge funds added GRDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for GRDN?

More buyers than sellers — 65% buying: Last quarter: 108 funds were net buyers (56 opened a brand new position + 52 added to an existing one). Only 58 were sellers (42 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for GRDN holders?

Elite ownership — 44% AUM from top-100 funds: 46 of 168 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in GRDN. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held GRDN?

Mostly new holders — 51% entered in last year: Only 5 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Guardian Pharmacy Svcs Inc (GRDN) following the 2026 Q2 hedge fund 13F filings?

As of today, GRDN has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), GRDN has gained -8.2% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Guardian Pharmacy Svcs Inc (GRDN)

Smart Money Signals — GRDN

Buying streak — 7 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +127% more funds vs a year ago

More buyers than sellers — 65% buying

More new buyers each quarter (+23 vs last Q)

Mostly new holders — 51% entered in last year

Value +61% but shares only +42% — price-driven

Acceleration phase — new buyers rushing in

Early stage — 63% of holders entered in last year

Elite ownership — 44% AUM from top-100 funds

Institutional Sentiment Summary — GRDN

Hedge Fund Ownership: GRDN

Market Analysis: GRDN

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: GRDN

Is It Too Late to Buy Guardian Pharmacy Svcs Inc (GRDN) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: GRDN

Statistics: GRDN

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Guardian Pharmacy Svcs Inc (GRDN)

Welcome to 13Foresight!